"83703-037-03" National Drug Code (NDC)

Flucelvax Quadrivalent 10 SYRINGE, GLASS in 1 CARTON (83703-037-03) / .5 mL in 1 SYRINGE, GLASS (83703-037-04)
(Bamboo US BidCo LLC)

NDC Code83703-037-03
Package Description10 SYRINGE, GLASS in 1 CARTON (83703-037-03) / .5 mL in 1 SYRINGE, GLASS (83703-037-04)
Product NDC83703-037
Product Type NameVACCINE
Proprietary NameFlucelvax Quadrivalent
Non-Proprietary NameInfluenza A Virus A/georgia/12/2022 Cvr-167 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/darwin/11/2021 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated),influenza B Virus B/singapore/wuh4618/2021 Antigen (mdck Cell Derived, Propiolactone Inactivated),influenza B Virus B/singapore/inftt-16-0610/2016 Antigen (mdck Cell Derived, Propiolactone Inactivated)
Dosage FormINJECTION, SUSPENSION
UsageINTRAMUSCULAR
Start Marketing Date20230701
End Marketing Date20240731
Marketing Category NameBLA
Application NumberBLA125408
ManufacturerBamboo US BidCo LLC
Substance NameINFLUENZA A VIRUS A/DARWIN/11/2021 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/GEORGIA/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/SINGAPORE/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
Strength15; 15; 15; 15
Strength Unitug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/83703-037-03